Spain · AEMPS CIMA

ANASMA 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
63925
Form
SUSPENSIÓN PARA INHALACIÓN EN ENVASE A PRESIÓN
Composition / generic term
salmeterol + fluticasona
Source strength
25 mcg salmeterol/250mcg propionato de fluticasona
Authorisation holder
Glaxosmithkline S.A.
Marketed in source snapshot
Yes

Source-listed ingredients

  • FLUTICASONA PROPIONATO — 250 µg
  • SALMETEROL XINAFOATO — 25 µg

These values do not establish equivalence or a dose recommendation.

Packages

  • ANASMA 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION, 1 inhalador de 120 dosis

Source and coverage

Open AEMPS CIMA →

Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Spain records →
ANASMA 25 MICROGRAMOS/250 MICROGRAMOS/INHALACION, SUSPENSION PARA INHALACION EN ENVASE A PRESION — Spain | Molindra Medicines